GlaxoSmithKline (GB:GSK)

GlaxoSmithKline (GSK) Stock Price & Analysis


GSK Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range1,244.14p - 2,644.18p
Previous Close1,392.2p
Average Volume (3M)8.22M
Market Cap
Enterprise Value6.95T
Total Cash (Recent Filing)£7.68B
Total Debt (Recent Filing)£20.99B
Price to Earnings (P/E)4.0
Jul 26, 2023
0.19 (0.01%)
Share Statistics
EPS (TTM)3.51
Shares Outstanding4,311,343,341
10 Day Avg. Volume11,123,383
30 Day Avg. Volume8,223,391
Standard Deviation0.05
Financial Highlights & Ratios
Price to Book (P/B)-557.52
Price to Sales (P/S)505.68
Price to Cash Flow (P/CF)1575.40
P/FCF Ratio2140.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside14.76% Upside
Rating ConsensusHold
Number of Analyst Covering11




What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest stock price was 1244.14p and its highest was 2644.18p in the past 12 months.
    What is GlaxoSmithKline’s market cap?
    Currently, no data Available
    When is GlaxoSmithKline’s upcoming earnings report date?
    GlaxoSmithKline’s upcoming earnings report date is Jul 26, 2023 which is in 56 days.
      How were GlaxoSmithKline’s earnings last quarter?
      GlaxoSmithKline released its earnings results on Apr 26, 2023. The company reported 0.37p earnings per share for the quarter, beating the consensus estimate of 0.333p by 0.037p.
        Is GlaxoSmithKline overvalued?
        According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does GlaxoSmithKline pay dividends?
          GlaxoSmithKline pays a Annually dividend of 14p which represents an annual dividend yield of 4.4%. See more information on GlaxoSmithKline dividends here
            What is GlaxoSmithKline’s EPS estimate?
            GlaxoSmithKline’s EPS estimate is £0.35.
              How many shares outstanding does GlaxoSmithKline have?
              GlaxoSmithKline has 4,094,980,700 shares outstanding.
                What happened to GlaxoSmithKline’s price movement after its last earnings report?
                GlaxoSmithKline reported an EPS of 0.37p in its last earnings report, beating expectations of 0.333p. Following the earnings report the stock price went down -3.866%.
                  Which hedge fund is a major shareholder of GlaxoSmithKline?
                  Currently, no hedge funds are holding shares in GB:GSK


                  GlaxoSmithKline Stock Smart Score

                  The GlaxoSmithKline Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.


                  Top 5 ETFs holding GSK

                  Market Value
                  Smart Score
                  Vang FTSE 100 Ptg.Shs GBP
                  iShares MSCI United Kingdom ETF
                  UBS ETF MSCI UK Shs -A- Distribution
                  UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF A- Capitalisation
                  UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF (GBP) A-UKdis
                  Up to five ETFs with an Outperform Smart Score that hold GSK. The ETFs are listed according to market value of GSK within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Hikma Pharmaceuticals
                  Dechra Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis